参考文献/References:
[1] Mckinnon BD,Kocbek V,Nirgianakis K,et al.Kinase signalling pathways in endometriosis:Potential targets for non-hormonal therapeutics[J].Human Reproduction Update,2016,22(3):382-403.
[2] Alvarado-Diza CP,Nbnez MT,Devoto L,et al.Iron overload-modulated nuclear factor kappa-B activation in human endometrial stromal cells as a mechanism postulated in endometriosis pathogenesis[J].Fertility and Sterility,2015,103(2):439-447.
[3] Zhao Y,Chen Y,Kuang Y,et al.Multiple beneficial roles of repressor of estrogen receptor activity(REA)in suppressing the progression of endometriosis[J].Endocrinology,2016,157(2):900-912.
[4] 高 扬,朱 艳.子宫内膜异位症合并不孕患者血清中基质金属蛋白酶-9、基质金属蛋白酶抑制剂-1、血管内皮生长因子可溶性受体、胰岛素生长因子-1、单核细胞趋化蛋白-1表达水平及临床意义[J].陕西医学杂志,2020,49(4):462-465.
[5] 梅雪佳,刘华建.子宫内膜异位症的发病机制研究进展[J].成都中医药大学,2019,19(18):37-38.
[6] 王国云,袁 明,姬苗苗.子宫内膜异位症发病机制研究进展[J].山东大学学报:医学版,2019,57(6):33-39.
[7] Casalechi M,Vieira-Lopes M,Quessada MP,et al.Endometriosis and related pelvic pain:Association with stress,anxiety and depressive symptoms[J].Minerva Obstetrics and Gynecology,2021,73(3):283-289.
[8] Conroy I,Mooney SS,Kavanagh S,et al.Pelvic pain:What are the symptoms and predictors for surgery,endometriosis and endometriosis severity[J].Obstetrics and Gynaecology,2021,61(5):765-772.
[9] 马西文.孕三烯酮联合GnRH-a辅助腹腔镜手术治疗中重度子宫内膜异位症临床研究[J].陕西医学杂志,2018,47(4):439-441.
[10] Cao Y,Liu X,Guo SW.Plasma high mobility group box 1(HMGB1),osteopontin(OPN),and hyaluronic acid(HA)as admissible biomarkers for endometriosis[J].Scientific Reports,2019,9(1):9272.
[11] 彭慧霞,尉春艳,陈和琼,等.MMP9特异性锤头状真核表达载体的构建及其对子宫内膜异位症细胞侵袭力的抑制作用[J].陕西医学杂志,2010,39(2):158-159.
[12] Agrawal D,Chen T,Irby R,et al.Osteopontin identified as lead marker of colon cancer progression using pooled sample expression profiling[J].Natl Cancer Inst,2002,94(7):513-521.
[13] 叶 黔,张金玲.子宫内膜异位症模型大鼠NF-κB及炎性因子、黏附因子变化及对细胞侵袭和凋亡的影响[J].中国计划生育学杂志,2020,28(10):1518-1522.
[14] Das R,Philip S,Mahabeleshwar GH,et al.Osteopontin:It's role in regulation of cell motility and nuclear factor κB-mediated urokinase type plasminogen activator expression[J].IUBMB Life,2002,57(6):441-447.
[15] 余 震,柳 洲.消瘤方对子宫内膜异位症大鼠盆腔粘连的影响[J].陕西中医,2022,43(1):13-16.
[16] 陈亚杰,闻 姬.子宫内膜异位症中西医认识及治疗研究进展[J].陕西中医,2021,42(10):1486-1489.
[17] Teti A,Farina AR,Villanova I,et al.Activation of MMP-2 by human GCT23 giant cell tumour cells induced by osteopontin,bone sialoprotein and GRGDSP peptides is RGD and cell shape change dependent[J].International Journal of Cancer,1998,77(1):82-93.
[18] 杨勇波,向 平.骨桥蛋白、环氧化酶-2在宫颈癌组织中的表达及其与化疗敏感性的相关性[J].蚌埠医学院学报,2021,46(4):464-467.
[19] Gabelli SB,Echeverria I,Alexander M,et al.Activation of PI3Kα by physiological effectors and by oncogenic mutations:Structural and dynamic effects[J].Biophysical Reviews,2014,6(1):89-95.
[20] 白治苗,李望舒,姚卫卫,等.核转录因子κB p65和骨桥蛋白在子宫内膜异位症中的表达及相关性研究[J].中国全科医学,2016,19(24):2915-2919.
相似文献/References:
[1]高 扬,朱 艳△.子宫内膜异位症合并不孕患者血清中基质金属蛋白酶-9、基质金属蛋白酶抑制剂-1、血管内皮生长因子可溶性受体、胰岛素生长因子-1、单核细胞趋化蛋白-1表达水平及临床意义[J].陕西医学杂志,2020,49(4):462.
GAO Yang,ZHU Yan..Expression of MMP-9,TIMP-1,sflt-1,IGF-1 and MCP-1 in serum of endometriosis patients with infertility and its clinical significance[J].,2020,49(6):462.
[2]王新香,张朝红.血清性激素和胰岛素水平对子宫内膜异位症合并不孕症的预测价值[J].陕西医学杂志,2021,50(1):41.[doi:DOI:10.3969/j.issn.1000-7377.2021.01.010]
[3]刘 丹,梁新新.育龄期子宫内膜异位症合并不孕症患者临床特征及腹腔镜术后辅助生殖妊娠结局影响因素分析[J].陕西医学杂志,2021,50(4):409.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.006]
LIU Dan,LIANG Xinxin.Clinical characteristics of endometriosis patients with infertility in childbearing age and influencing factors of assisted reproductive pregnancy outcome after laparoscopic surgery[J].,2021,50(6):409.[doi:DOI:10.3969/j.issn.1000-7377.2021.04.006]
[4]屈 慧,皇 海,张 蕊.血清细胞角蛋白18、骨桥蛋白水平与原发性喉癌患者临床分期相关性研究[J].陕西医学杂志,2021,50(11):1452.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.033]
QU Hui,HUANG Hai,ZHANG Rui.Correlation between serum cytokeratin 18,osteopontin levels and clinical stage of patients with primary laryngeal carcinoma[J].,2021,50(6):1452.[doi:DOI:10.3969/j.issn.1000-7377.2021.11.033]
[5]白治苗,刘玉锋,赵 乐,等.核因子-κB p65和骨桥蛋白在子宫内膜癌组织与细胞中的表达及相关性研究[J].陕西医学杂志,2022,51(3):370.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.025]
BAI Zhimiao,LIU Yufeng,ZHAO Le,et al.Expression of nuclear factor kappa B p65 and osteopontin in endometrial carcinoma and their correlation[J].,2022,51(6):370.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.025]
[6]高 鑫,贾红娥,李 倩,等.盆底三维超声参数联合血清基质金属蛋白酶-1、骨桥蛋白、结缔组织生长因子水平对压力性尿失禁疾病严重程度的预测价值[J].陕西医学杂志,2023,52(2):149.[doi:DOI:10.3969/j.issn.1000-7377.2023.02.007]
GAO Xin,JIA Hong'e,LI Qian,et al.Predictive value of three-dimensional pelvic floor ultrasound parameters combined with serum MMP-1,OPN and CTGF in severity of stress urinary incontinence[J].,2023,52(6):149.[doi:DOI:10.3969/j.issn.1000-7377.2023.02.007]
[7]罗培跃,陈 涛,邹 俊,等.纳米细菌诱导肾结石形成中肠道草酸降解菌变化初步研究[J].陕西医学杂志,2023,52(8):977.[doi:DOI:10.3969/j.issn.1000-7377.2023.08.008]
LUO Peiyue,CHEN Tao,ZOU Jun,et al.Preliminary study on changes of oxalate-degrading bacteria in nanobacteria-induced kidney stone formation[J].,2023,52(6):977.[doi:DOI:10.3969/j.issn.1000-7377.2023.08.008]
[8]孙利娟,黄香平,张多多,等.沉默miR-6771-3p通过靶向AXIN2/Wnt信号通路调控异位子宫内膜间质细胞增殖和迁移实验研究[J].陕西医学杂志,2023,52(11):1468.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.004]
SUN Lijuan,HUANG Xiangping,ZHANG Duoduo,et al.Silencing miR-6771-3p regulates the proliferation and migration of ectopic endometrial stromal cells by targeting AXIN2/Wnt signaling pathway[J].,2023,52(6):1468.[doi:DOI:10.3969/j.issn.1000-7377.2023.11.004]
[9]付 钰,束明阳,杨 波.即刻种植联合富血小板纤维蛋白固定种植体在前牙缺失治疗中的疗效及对患者龈沟液骨桥蛋白的影响[J].陕西医学杂志,2024,(1):51.[doi:DOI:10.3969/j.issn.1000-7377.2024.01.011]
FU Yu,SHU Mingyang,YANG Bo.Efficacy of immediate implantation combined with PRF in immediate implantation of anterior teeth loss and the influence of OPN level in gingival crevicular fluid[J].,2024,(6):51.[doi:DOI:10.3969/j.issn.1000-7377.2024.01.011]
[10]严兆华,方醒艺,姚美华,等.外泌体和免疫细胞在子宫内膜异位症发生与发展中的作用研究进展[J].陕西医学杂志,2025,54(2):285.[doi:DOI:10.3969/j.issn.1000-7377.2025.02.030]
YAN Zhaohua,FANG Xingyi,YAO Meihua,et al.Research progress on the role of exosomes and immune cells in the occurrence and development of endometriosis[J].,2025,54(6):285.[doi:DOI:10.3969/j.issn.1000-7377.2025.02.030]